Prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home.
OBJECTIVE
To determine the prevalence of a hemoglobin A(1c) less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein (LDL) cholesterol less than 100 mg/dL in older persons with diabetes mellitus who were not terminally ill in an academic nursing home.


METHODS
We investigated in all older diabetic individuals who were not terminally ill in an academic nursing home the prevalence of a hemoglobin A(1c) less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum LDL cholesterol less than 100 mg/dL.


METHODS
An academic nursing home.


METHODS
Of 202 persons, 62 (31%) had diabetes mellitus. The 62 diabetic individuals included 33 women and 29 men, mean age 73 +/- 9 years.


METHODS
Prevalence of hemoglobin A(1c) less than 7.0%, of blood pressure less than 130/80 mm Hg, and of serum LDL cholesterol less than 100 mg/dL.


RESULTS
The hemoglobin A(1c) was less than 7.0% in 55 (89%) of 62 diabetic individuals. The blood pressure was less than 130/80 mm Hg in 52 (84%) of 62 diabetic individuals. The serum LDL cholesterol was less than 100 mg/dL in 55 (89%) of 62 diabetic individuals.


CONCLUSIONS
As recommended by the American Diabetes Association, the hemoglobin A(1c) was less than 7.0% in 55 (89%) of 62 diabetic individuals, the blood pressure was less than 130/80 mm Hg in 52 (84%) of 62 diabetic individuals, and the serum LDL cholesterol was less than 100 mg/dL in 55 (89%) of 62 diabetic individuals in an academic nursing home.
Joseph
Julie
J
Department of Medicine, Divisions of Geriatrics, New York Medical College, Valhalla, NY, USA.
Koka
Madhavi
M
Aronow
Wilbert S
WS
D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001794:Blood Pressure; D008078:Cholesterol, LDL / Q000097:blood*; D003920:Diabetes Mellitus / Q000097:blood*; D005260:Female; D015577:Geriatric Assessment / Q000706:statistics & numerical data*; D006442:Glycated Hemoglobin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009518:New York / Q000453:epidemiology; D009735:Nursing Homes; D015995:Prevalence
D000806:Angiotensin-Converting Enzyme Inhibitors; D008078:Cholesterol, LDL; D006442:Glycated Hemoglobin; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors